Accordingly, EGR1, EGR2, and EGR3 were differentially expressed genes (DEGs) in several cancers, such as bladder urothelial carcinoma (BLCA), BRCA, and lung adenocarcinoma (LUAD). Here, EGR2 is linked to bladder transitional cell carcinoma.